2021
DOI: 10.1016/j.drugpo.2021.103361
|View full text |Cite
|
Sign up to set email alerts
|

Coverage of medical cannabis by Canadian news media: Ethics, access, and policy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…In agreement with this finding, one study noted that these effects were magnified by commercial web sites compared to other sources of online information (e.g., government, health portal, non-profit), indicating the biases associated with commercial interests [ 26 ]. Across other forms of media such as news outlets and online discussion forums, the quality and accuracy of cannabis-related health information, as well as reporting of risks, was also found to be poor [ 26 , 39 41 ]. It is worth mentioning that these aforementioned studies did not use the DISCERN instrument, which in addition to quality, assesses the reliability of consumer health information, as opposed to accuracy.…”
Section: Discussionmentioning
confidence: 99%
“…In agreement with this finding, one study noted that these effects were magnified by commercial web sites compared to other sources of online information (e.g., government, health portal, non-profit), indicating the biases associated with commercial interests [ 26 ]. Across other forms of media such as news outlets and online discussion forums, the quality and accuracy of cannabis-related health information, as well as reporting of risks, was also found to be poor [ 26 , 39 41 ]. It is worth mentioning that these aforementioned studies did not use the DISCERN instrument, which in addition to quality, assesses the reliability of consumer health information, as opposed to accuracy.…”
Section: Discussionmentioning
confidence: 99%
“…However, our sub-analysis by website typology (reported in Table 1) identified a large variability, with side effects mentioned more frequently by health portals and non-profit organizations and much less frequently by commercial websites and news outlets, thus suggesting a bias associated with commercial interests and newsworthiness. Poor reporting on the risks associated with medical cannabis was also observed in studies on print news outlets in California (Halvorson et al, 2018) and in Canadian news media (Gunning & Illes, 2021).…”
Section: Discussionmentioning
confidence: 82%
“…In Canada and England, any legalization effects may have been diminished by public/media discussions in the period leading up to legalization. For example, in 2017, there was wide-spread media coverage of a campaign in England to prescribe medical cannabis for a child with epilepsy ( Deacon, 2019 ) and the federal bill to legalize cannabis in Canada was also widely reported on when it was first passed ( Gunning and Illes, 2021 ); this publicity may have decreased perceptions of cannabis risks. Further, despite medical legalization of cannabis in England, access is heavily restricted and very few people have received a prescription ( Dowden, 2021 ) and so legalization may not have made any noticeable difference to perceptions.…”
Section: Discussionmentioning
confidence: 99%